β‐Cryptoxanthin Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells Through Retinoic Acid Receptor
Publisher：
John Wiley & Sons Inc
E-ISSN：
1613-4133|62|2|mnfr.201700489-mnfr.201700489
ISSN：
1613-4125
Source：
MOLECULAR NUTRITION & FOOD RESEARCH,
Vol.62,
Iss.2, 2018-01,
pp. : n/a-n/a
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Previous
Menu
Next
Abstract
Scopeβ‐Cryptoxanthin is an abundant carotenoid in fruits and vegetables that can be quantified in human blood serum. Yet, contrary to other carotenoids, its effects on endothelial cells and angiogenesis remain unknown.Methods and resultsHuman umbilical vein endothelial cells (HUVEC) are treated with 0.01, 0.1, or 1 μm of β‐cryptoxanthin. Antioxidant activity is determined by its free radical scavenging and oxygen‐radical absorbance capacity. The effect on migration and formation of tubular structures is studied. Additionally, effect on angiogenesis is also analyzed using an in vivo model. β‐Cryptoxanthin exhibits scavenging ability, having an antioxidant effect on HUVEC. Interestingly, β‐cryptoxanthin reduces their migration and angiogenesis, even in the presence of vascular endothelial growth factor (VEGF). Additionally, such carotenoid inhibits in vivo angiogenesis induced by VEGF. In addition, treatment of HUVEC with LE540 (retinoic acid receptor [RAR] panantagonist) inhibits β‐cryptoxanthin antiangiogenic effect on HUVEC.Conclusionβ‐Cryptoxanthin inhibits angiogenesis through RAR. Thus, this carotenoid and food containing it may be useful for the prevention and treatment of angiogenic pathologies. That includes tumoral growth and wet macular degeneration associated with aging. To the best of our knowledge, this is the first report of the antioxidant effect and antiangiogenic activity of this carotenoid on HUVEC, both in vitro and in vivo.
Access to resources
Recommend
